Kliniczna i immunologiczna ocena bezobjawowych zakażeń SARS-CoV-2

Quan-Xin Long i wsp. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine (2020) (dostępny pełen tekst)

These data suggest that asymptomatic individuals had a weaker immune response to SARS-CoV-2 infection. The reduction in IgG and neutralizing antibody levels in the early convalescent phase might have implications for immunity strategy and serological surveys.

Together, these data might indicate the risks of using COVID-19 ‘immunity passports’ and support the prolongation of public health interventions, including social distancing, hygiene, isolation of high-risk groups and widespread testing.

Nature Medicine 18 czerwca 2020

0 replies on “Kliniczna i immunologiczna ocena bezobjawowych zakażeń SARS-CoV-2”